Anixa Biosciences (ANIX) Interest & Investment Income (2010 - 2026)
Anixa Biosciences' Interest & Investment Income came in at $112,000 for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 28.2% from $156,000 a year earlier but up 0.9% from the prior quarter.
Anixa Biosciences (ANIX) Interest & Investment Income (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, Anixa Biosciences reported Interest & Investment Income of $533,000, down 30.7% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at $673,000, down 40.6% from FY2024.
- Interest & Investment Income carries a five-year compound annual growth rate of 81.8% (FY2020 to FY2025).
- Going back by fiscal year, Interest & Investment Income was $1.13 million in FY2024 (+4.8%), $1.08 million in FY2023 (+939.4%), $104,000 in FY2022 and $2,000 in FY2021 (-94.1%).
- The five-year range for quarterly Interest & Investment Income is $1,000 (fiscal Q1 2022) to $330,000 (fiscal Q4 2023).
- The fastest year-over-year change in Interest & Investment Income over five years came in fiscal Q4 2023 (growth of 312.5%), and the weakest in fiscal Q1 2025 (a decline of 45.8%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Anixa Biosciences | 102.02 Mn | 100.75 Mn | - | 112,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 112,000.00 |
| Apr 30, 2026 | 111,000.00 |
| Oct 31, 2025 | 154,000.00 |
| Jul 31, 2025 | 156,000.00 |
| Apr 30, 2025 | 190,000.00 |
| Jan 31, 2025 | 173,000.00 |
| Oct 31, 2024 | 250,000.00 |
| Jul 31, 2024 | 277,000.00 |
| Apr 30, 2024 | 287,000.00 |
| Jan 31, 2024 | 319,000.00 |
| Oct 31, 2023 | 330,000.00 |
| Jul 31, 2023 | 296,000.00 |
| Apr 30, 2023 | 253,000.00 |
| Jan 31, 2023 | 202,000.00 |
| Oct 31, 2022 | 80,000.00 |
| Jul 31, 2022 | 22,000.00 |
| Apr 30, 2022 | 1,000.00 |
| Jan 31, 2022 | 1,000.00 |
| Jul 31, 2021 | 626.00 |
| Apr 30, 2021 | 393.00 |
Anixa Biosciences Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();